Key facts
- AiM Medical Robotics’s last known valuation is $34.0M (Jun 2025).
- It has raised $11.5M across 2 recorded rounds; the latest was Early Stage VC ($6.7M) in Jun 2025.
- Notable investors include Keiretsu Forum, New York Angels, MassRobotics, IQ Capital Partners, Worcester Polytechnic Institute Endowment — 13 tracked in total.
- AiM Medical Robotics has filed 4 Form Ds with the SEC since 2023, most recently Jun 2025 ($6.7M sold to 102 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for AiM Medical Robotics
Funding rounds
2 roundsAbout AiM Medical Robotics
Developer of a compatible surgical robot designed to increase outcomes for patients undergoing neurosurgery for functional brain disorders. The company's surgical robotic platform combines surgical planning and procedure with MR functional robotics, providing precise trajectory guidance for neurosurgical procedures, enabling healthcare providers to improve patient outcomes.
- Sector
- Healthcare
- HQ
- Worcester, MA, United States
- Founded
- 2018
- Employees
- 9
- Website
- aimmedicalrobotics.com/
- Ownership
- Privately Held (backing)
AiM Medical Robotics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AiM Medical Robotics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AiM Medical Robotics in its N-PORT filings yet. We sweep new filings monthly.